A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study is a Phase 2, randomized, double-blind, placebo controlled, pilot study designed to evaluate the efficacy and safety of PRM-151 administered through Week 24 to subjects with IPF.
Epistemonikos ID: e51de31e0c3d0711bcf6451927dceeda86324f2b
First added on: May 12, 2024